Commonwealth Equity Services’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.58M | Buy |
|
|||||
|
2025
Q2 | $1.49M | Sell |
|
|||||
|
2025
Q1 | $1.62M | Sell |
|
|||||
|
2024
Q4 | $2.19M | Sell |
|
|||||
|
2024
Q3 | $2.71M | Sell |
|
|||||
|
2024
Q2 | $4.12M | Sell |
|
|||||
|
2024
Q1 | $5.82M | Buy |
|
|||||
|
2023
Q4 | $4.97M | Sell |
|
|||||
|
2023
Q3 | $6.02M | Buy |
|
|||||
|
2023
Q2 | $5.9M | Buy |
|
|||||
|
2023
Q1 | $4.73K | Buy |
|
|||||
|
2022
Q4 | $4.28M | Buy |
|
|||||
|
2022
Q3 | $3.82M | Buy |
|
|||||
|
2022
Q2 | $3.73M | Buy |
|
|||||
|
2022
Q1 | $4.71M | Sell |
|
|||||
|
2021
Q4 | $7.07M | Buy |
|
|||||
|
2021
Q3 | $6.82M | Sell |
|
|||||
|
2021
Q2 | $6.34M | Sell |
|
|||||
|
2021
Q1 | $5.63M | Sell |
|
|||||
|
2020
Q4 | $5.49M | Sell |
|
|||||
|
2020
Q3 | $4.98M | Sell |
|
|||||
|
2020
Q2 | $4.62M | Sell |
|
|||||
|
2020
Q1 | $3.38M | Buy |
|
|||||
|
2019
Q4 | $3.83M | Buy |
|
|||||
|
2019
Q3 | $3.31M | Sell |
|
|||||
|
2019
Q2 | $3.59M | Buy |
|
|||||
|
2019
Q1 | $3.33M | Buy |
|
|||||
|
2018
Q4 | $2.54M | Buy |
|
|||||
|
2018
Q3 | $2.98M | Sell |
|
|||||
|
2018
Q2 | $2.49M | Buy |
|
|||||
|
2018
Q1 | $2.32M | Sell |
|
|||||
|
2017
Q4 | $2.52M | Buy |
|
|||||
|
2017
Q3 | $2.45M | Sell |
|
|||||
|
2017
Q2 | $2.31M | Buy |
|
|||||
|
2017
Q1 | $1.58M | Sell |
|
|||||
|
2016
Q4 | $1.35M | Sell |
|
|||||
|
2016
Q3 | $1.48M | Sell |
|
|||||
|
2016
Q2 | $1.47M | Sell |
|
|||||
|
2016
Q1 | $1.36M | Sell |
|
|||||
|
2015
Q4 | $1.44M | Buy |
|
|||||
|
2015
Q3 | $1.14M | Buy |
|
|||||
|
2015
Q2 | $1.25M | Buy |
|